Take Solutions Ltd
TAKETake Solutions Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
Biggest watch item: the P/E sits at the 100th percentile of its own range — the multiple has already done part of the work.
The price is in a confirmed uptrend (29 weeks in) while the P/E sits at the 100th percentile of its own 10-year range. Underneath, the last four quarters read mixed — profit −97.7% year on year, and 55% of the last 3 years' profit arrived as cash. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Take Solutions Ltd trades at ₹43.6, in a confirmed uptrend and 29 weeks into that stage. That is +35.1% against its own 200-day average. It sits at 87% of a 52-week range of ₹7 to ₹49. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 45 straight weeks.
Today the stock is in a confirmed uptrend — week 29 of stage 2, confirmed. At ₹43.6 it trades +35.1% versus its 200-day average and sits at 87% of its 52-week range (₹7–₹49).
Against the market, two honest reads. Cumulative: over the last 10.2 years the stock moved −67% while the NIFTY 500 moved +277% — behind the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 45 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.
Take Solutions Ltd trades at 3,222.0× P/E, about the priciest it has ever traded. Its long-run median P/E is 13.4×, measured across 10.0 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 3,222.0× is about the priciest it has ever traded, against a long-run median of 13.4× measured over 10.0 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Put together: the multiple is full against its own past, so the story rests on the earnings line underneath it, not the multiple.
A quarterly PEG curve, which only the second data source carries, is not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Take Solutions Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 5 quarters across 1 curve, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Profit | — | — | — | −7.3% |
| EPS | — | — | — | −7.8% |
| Share price | +444.5% | +40.4% | −3.0% | −10.2% |
4-Factor Sector Score
58.7/100 — rank 6 of 36 in Miscellaneous · 57% evidence confidence
Take Solutions Ltd scores 58.7 out of 100 against the 36 companies it is compared with in Miscellaneous, ranking 6. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 24.7 + 8.5 + 8.5 + 17 = 58.7. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
Take Solutions Ltd reported ₹0.0 Cr of revenue in the Dec 25 quarter. The last full year, FY25, came in at ₹0.0 Cr. The last four reported quarters add to ₹0.0 Cr. A multi-year compound rate is not shown because the annual history behind it is too short to compute one honestly.
FY25 revenue came in at ₹0.0 Cr (−100.0% on the year). The latest quarter (Dec 25) printed ₹0.0 Cr, null year on year.
Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
A clean operating margin is not in our numbers for Take Solutions Ltd — its accounts do not report the operating-profit line this section reads, which is common for lenders and holding companies. The sections above and below carry the readings this company's filings do support.
This company's accounts do not report the operating-profit line this section reads — common for lenders and holding companies classified outside the financial bucket. The revenue and net-profit sections are the cleaner reads for Take Solutions Ltd.
🚨 Why the margin moved: operating margin went −2,839.1 pp year on year while gross margin went +47.9 pp — the loss came mostly below the gross line: operating leverage, with costs spread over a bigger revenue base.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Take Solutions Ltd earned ₹1.1 Cr of net profit in the Dec 25 quarter, −97.7% year on year. Full-year FY25 profit was ₹37.5 Cr. The 10-year compound rate is −7.3%. The same quarter a year earlier earned ₹47.7 Cr. 9 of the last 12 reported quarters were loss-making.
Dec 25 profit was ₹1.1 Cr, −97.7% year on year. On the full year, FY25 printed ₹37.5 Cr (null), and the 10-year compound rate is −7.3%.
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
Over the last 3 fiscal years 55% of Take Solutions Ltd's reported profit arrived as operating cash — a gap worth watching. In FY25 that was ₹−16.4 Cr of operating cash against ₹37.5 Cr of profit. After ₹−30.0 Cr of capital spending, ₹14.0 Cr was left as free cash.
FY25: operating cash of ₹−16.4 Cr against reported profit of ₹37.5 Cr, leaving free cash of ₹14.0 Cr after ₹−30.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 55% of profit.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
🚨 Why conversion sits at 55%: the cash cycle tightened 116 days between FY20 and FY25 — cash that used to wait in the cycle now reaches the bank sooner. Less than 70% of profit arriving as cash is the thing to watch on this page.
Router verdict: no single sink dominates — the next section checks both the working-capital cycle and the capital spending.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
Take Solutions Ltd's cash conversion cycle runs 0 days in FY25, down from 116 days in FY20. Capital spending ran ₹−87.0 Cr over the last 3 years.
FY25: debtors at 0 days (an asset-light business — no inventory to speak of) — for a full cycle of 0 days, tighter than FY20's 116.
On the investment side: capital spending of ₹−87.0 Cr over the last 3 fiscal years against ₹18.0 Cr of depreciation — spending at or below maintenance level. Capital work-in-progress stands at ₹0.0 Cr (FY25) — capacity paid for but not yet earning.
The synthesis: neither the cycle nor the build-out is hoarding the cash — the machine is reasonably clean.
Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified
Take Solutions Ltd earns a ROCE of 11% in FY25. That is up from a trough of −22% in FY24. Return on invested capital clears the cost of that capital by −18.6 percentage points, so growth here is not yet paying for the capital it uses. The wiring behind it is −3,322.8% net margin on 0.04× asset turns.
FY25 ROCE is 11%, recovered from a FY24 trough of −22% — the full ladder below shows the fall and the climb, undoctored.
🚨 Why the return is what it is — the wiring (FY24): −3,322.8% net margin × 0.04× asset turns × −9.92× balance-sheet leverage ≈ 1,318.5% on equity. Margin does its share; leverage is modest — this is an earned return, not a borrowed one.
The capstone test — ROIC − WACC: −6.6% − 12.0% = a −18.6 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Negative — growth at these returns destroys value until the returns recover.
Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified
Take Solutions Ltd's net worth is negative — it owes more than it owns — so a debt-to-equity ratio is not meaningful here. On the annual view that ratio went from 0.43 in FY22 to −4.11 in FY24. The returns elsewhere on this page are therefore earned rather than borrowed.
Dec 24: total debt of ₹8.0 Cr against shareholder equity of ₹−14.0 Cr — a debt-to-equity of −0.57. On the annual view, debt-to-equity went from 0.43 (FY22) to −4.11 (FY24). The returns on this page are earned, not borrowed.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Promoters cut 53.4 points of Take Solutions Ltd over 8 quarters, the biggest move on the register. That takes promoters to 0.0% of the company. Foreign institutions moved +0.3 points over the same window, to 0.3%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Promoters: −53.4 points over 8 quarters to 0.0%; Foreign institutions: +0.3 points over 8 quarters to 0.3%; Domestic institutions: +0.0 points over 8 quarters to 0.0%. Note the structure: promoters hold under 20% — this is a widely-held company where institutions, not a family, set the direction.
🚨 Why the register moved: promoters drove it (−53.4 points) — distribution into the market’s bid.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Take Solutions Ltd: the Z-score is not available for this stock, so we say so rather than invent one. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure. The debt, cash-flow and return sections above carry the balance-sheet evidence this page does hold, and each of them states its own reporting date.
The safety line in one sentence: the Z-score is not available for this stock, so we say so rather than invent one.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Gulshan Polyols LtdGULPOLY | 74.3/100Favorable setup87% evidence | ASLEEP | 27.5/35 Revenue 9.4% · PAT 100% · OPM change 7 pp 95% evidence | 19.1/25 ROCE 18.3% · OPM 13% 95% evidence | 13.1/20 P/E 8× · PEG — 50% evidence | 14.6/20 RS sector 13.6% · RS bench 12.7% · 1Y 8.5%8 of 12 weeks ahead 100% evidence |
| Exact sum: 27.5 + 19.1 + 13.1 + 14.6 = 74.3 · Decision use: Confirmed research leader: earnings, capital efficiency and relative strength agree. Move to management, catalyst and risk diligence. | ||||||
| 2Sagility LtdSAGILITY | 66.2/100Favorable setup87% evidence | BASING | 24.7/35 Revenue 29.4% · PAT 49.3% · OPM change 0 pp 100% evidence | 15.8/25 ROCE 13.4% · OPM 22% 100% evidence | 13.9/20 P/E 19.3× · PEG 1.02 65% evidence | 11.8/20 RS sector 7.2% · RS bench -7.7% · 1Y -6.4%0 of 10 weeks ahead 70% evidence |
| Exact sum: 24.7 + 15.8 + 13.9 + 11.8 = 66.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3IIRM Holdings India Ltd526530 | 64.4/100Mixed-positive evidence75% evidence | LEADER | 16.3/35 Revenue 14.9% · PAT 12.7% · OPM change 1.1 pp 95% evidence | 19.0/25 ROCE 20.4% · OPM 24.6% 76% evidence | 9.8/20 P/E 37.2× · PEG — 15% evidence | 19.3/20 RS sector 40% · RS bench 38.6% · 1Y 71.7%12 of 12 weeks ahead 100% evidence |
| Exact sum: 16.3 + 19 + 9.8 + 19.3 = 64.4 · Decision use: Price leads the evidence: RS versus the benchmark is 38.6%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 4Exhicon Events Media Solutions Ltd543895 | 63.4/100Thin evidence · provisional60% evidence | ASLEEP | 19.0/35 Revenue 100% · PAT 100% · OPM change 0 pp 48% evidence | 20.1/25 ROCE 29.5% · OPM 28% 76% evidence | 13.2/20 P/E 18.8× · PEG — 50% evidence | 11.1/20 RS sector 2.2% · RS bench -3.2% · 1Y -4.9%0 of 10 weeks ahead 70% evidence |
| Exact sum: 19 + 20.1 + 13.2 + 11.1 = 63.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5Aeroflex Enterprises LtdAEROENTER | 62.5/100Mixed-positive evidence87% evidence | LEADER | 19.7/35 Revenue 27.5% · PAT 100% · OPM change -5 pp 95% evidence | 14.7/25 ROCE 12.6% · OPM 9% 95% evidence | 8.9/20 P/E 9.5× · PEG — 50% evidence | 19.2/20 RS sector 36.3% · RS bench 34.8% · 1Y 32.4%12 of 12 weeks ahead 100% evidence |
| Exact sum: 19.7 + 14.7 + 8.9 + 19.2 = 62.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Take Solutions Ltdthis pageTAKE | 58.7/100Thin evidence · provisional57% evidence | 24.7/35 Revenue — · PAT 100% · OPM change 2932.2 pp 57% evidence | 8.5/25 ROCE 11.2% · OPM — 80% evidence | 8.5/20 P/E 3222× · PEG — 15% evidence | 17.0/20 RS sector 71.1% · RS bench 71.4% · 1Y 384%11 of 12 weeks ahead to 2026-05-03 70% evidence | |
| Exact sum: 24.7 + 8.5 + 8.5 + 17 = 58.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7Global Education LtdGLOBAL | 57.8/100Mixed-positive evidence80% evidence | ASLEEP | 14.2/35 Revenue 28.2% · PAT 3.3% · OPM change 0.3 pp 95% evidence | 19.8/25 ROCE 29.2% · OPM 41% 95% evidence | 10.3/20 P/E 20.8× · PEG — 15% evidence | 13.5/20 RS sector 16.7% · RS bench 16% · 1Y 63%0 of 12 weeks ahead 100% evidence |
| Exact sum: 14.2 + 19.8 + 10.3 + 13.5 = 57.8 · Decision use: Price leads the evidence: RS versus the benchmark is 16%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 8GMR Airports LtdGMRAIRPORT | 56.6/100Mixed-positive evidence74% evidence | FADING | 22.7/35 Revenue 38.8% · PAT 100% · OPM change 1 pp 74% evidence | 11.3/25 ROCE 11.6% · OPM 37% 100% evidence | 8.7/20 P/E 191× · PEG — 15% evidence | 13.9/20 RS sector 2.6% · RS bench 1.9% · 1Y 14.3%8 of 12 weeks ahead 100% evidence |
| Exact sum: 22.7 + 11.3 + 8.7 + 13.9 = 56.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 9R K Swamy LtdRKSWAMY | 56.5/100Mixed-positive evidence65% evidence | FADING | 22.5/35 Revenue 14.3% · PAT 17.3% · OPM change 2.6 pp 95% evidence | 15.3/25 ROCE 12.3% · OPM 10.4% 95% evidence | 10.4/20 P/E 19.5× · PEG — 15% evidence | 8.3/20 RS sector — · RS bench -16.7% · 1Y —4 of 5 weeks ahead 25% evidence |
| Exact sum: 22.5 + 15.3 + 10.4 + 8.3 = 56.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Aegis Vopak Terminals LtdAEGISVOPAK | 56.1/100Mixed-positive evidence60% evidence | BREAKING OUT | 21.9/35 Revenue 25.9% · PAT 40.9% · OPM change 2 pp 95% evidence | 13.2/25 ROCE 7.6% · OPM 77% 76% evidence | 9.2/20 P/E 110× · PEG — 15% evidence | 11.8/20 RS sector — · RS bench 12% · 1Y 9%7 of 10 weeks ahead 25% evidence |
| Exact sum: 21.9 + 13.2 + 9.2 + 11.8 = 56.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 11Inox Green Energy Services LtdINOXGREEN | 54.1/100Mixed-positive evidence75% evidence | FADING | 22.2/35 Revenue 16.5% · PAT 100% · OPM change -13.2 pp 95% evidence | 9.1/25 ROCE 8.4% · OPM -2.2% 76% evidence | 9.6/20 P/E 61.3× · PEG — 15% evidence | 13.2/20 RS sector 0.5% · RS bench -0.3% · 1Y 24.2%8 of 12 weeks ahead 100% evidence |
| Exact sum: 22.2 + 9.1 + 9.6 + 13.2 = 54.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 12Parin Enterprises LtdPARIN | 53.7/100Mixed-positive evidence63% evidence | BREAKING OUT | 19.4/35 Revenue 100% · PAT 100% · OPM change -3 pp 48% evidence | 11.6/25 ROCE 10.8% · OPM 9% 95% evidence | 8.8/20 P/E 124× · PEG — 15% evidence | 13.9/20 RS sector 15.7% · RS bench 15% · 1Y 76.3%9 of 12 weeks ahead 100% evidence |
| Exact sum: 19.4 + 11.6 + 8.8 + 13.9 = 53.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 13Anzen India Energy Yield Plus TrustANZEN | 50.5/100Mixed-positive evidence60% evidence | FADING | 20.7/35 Revenue 100% · PAT 100% · OPM change -9 pp 95% evidence | 9.1/25 ROCE 3.3% · OPM 80% 76% evidence | 9.3/20 P/E 102× · PEG — 15% evidence | 11.4/20 RS sector — · RS bench 7.3% · 1Y 14.1%2 of 10 weeks ahead 25% evidence |
| Exact sum: 20.7 + 9.1 + 9.3 + 11.4 = 50.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Eveready Industries India LtdEVEREADY | 50.1/100Mixed-positive evidence94% evidence | TURNING | 18.9/35 Revenue 8.7% · PAT 100% · OPM change 1 pp 100% evidence | 13.6/25 ROCE 17.2% · OPM 15% 100% evidence | 8.8/20 P/E 16.3× · PEG 2.1 100% evidence | 8.8/20 RS sector -9.5% · RS bench 1% · 1Y -12.8%5 of 10 weeks ahead 70% evidence |
| Exact sum: 18.9 + 13.6 + 8.8 + 8.8 = 50.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 15Jai Corp LtdJAICORPLTD | 49.8/100Mixed-negative evidence74% evidence | ASLEEP | 19.6/35 Revenue 2.7% · PAT -40.4% · OPM change 9 pp 95% evidence | 12.7/25 ROCE 13.3% · OPM 15% 95% evidence | 10.8/20 P/E 18.7× · PEG — 15% evidence | 6.7/20 RS sector -8.2% · RS bench -20% · 1Y -6.5%4 of 10 weeks ahead 70% evidence |
| Exact sum: 19.6 + 12.7 + 10.8 + 6.7 = 49.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 16TCC Concept LtdTCC | 47.2/100Mixed-negative evidence81% evidence | ASLEEP | 16.6/35 Revenue 100% · PAT 51.1% · OPM change -45 pp 95% evidence | 11.8/25 ROCE 5.7% · OPM 36% 95% evidence | 14.3/20 P/E 18.7× · PEG — 50% evidence | 4.5/20 RS sector -17.6% · RS bench -40.7% · 1Y -48.8%0 of 11 weeks ahead 70% evidence |
| Exact sum: 16.6 + 11.8 + 14.3 + 4.5 = 47.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17Jindal Photo LtdJINDALPHOT | 46.6/100Mixed-negative evidence77% evidence | ASLEEP | 20.4/35 Revenue 100% · PAT -80% · OPM change 15 pp 95% evidence | 10.1/25 ROCE -1.4% · OPM 98% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 6.1/20 RS sector -14.8% · RS bench -15.1% · 1Y 26.3%1 of 12 weeks ahead 100% evidence |
| Exact sum: 20.4 + 10.1 + 10 + 6.1 = 46.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 18Aqylon Nexus LtdAQYLON | 45.9/100Mixed-negative evidence72% evidence | ASLEEP | 18.5/35 Revenue 100% · PAT 100% · OPM change 2358 pp 71% evidence | 18.8/25 ROCE 131% · OPM 58% 95% evidence | 8.6/20 P/E 819× · PEG — 15% evidence | 0.0/20 RS sector -76% · RS bench -76% · 1Y -80.8%0 of 12 weeks ahead 100% evidence |
| Exact sum: 18.5 + 18.8 + 8.6 + 0 = 45.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19Shipping Corporation of India Land & Assets LtdSCILAL | 42.9/100Mixed-negative evidence80% evidence | ASLEEP | 24.2/35 Revenue 23.8% · PAT 100% · OPM change 13 pp 95% evidence | 5.0/25 ROCE 1.3% · OPM -14% 95% evidence | 9.4/20 P/E 65.9× · PEG — 15% evidence | 4.3/20 RS sector -13.8% · RS bench -14.3% · 1Y -17.8%2 of 12 weeks ahead 100% evidence |
| Exact sum: 24.2 + 5 + 9.4 + 4.3 = 42.9 · Decision use: Acceleration candidate, not a confirmed leader: earnings are strong but sector-relative strength is -13.8% and the one-year return is -17.8%. Do not upgrade until sector-relative strength is above zero and another reported period confirms growth. | ||||||
| 20TruAlt Bioenergy LtdTRUALT | 40.1/100Mixed-negative evidence63% evidence | TURNING | 10.7/35 Revenue 1.8% · PAT -8.1% · OPM change 7 pp 100% evidence | 9.3/25 ROCE 10.4% · OPM 21% 100% evidence | 10.1/20 P/E 26.4× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —6 of 12 weeks ahead 0% evidence |
| Exact sum: 10.7 + 9.3 + 10.1 + 10 = 40.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 21GKW LtdGKWLIMITED | 39.2/100Mixed-negative evidence71% evidence | ASLEEP | 10.9/35 Revenue -13.5% · PAT 0% · OPM change -2 pp 95% evidence | 9.2/25 ROCE 0.5% · OPM 84% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 9.1/20 RS sector -0.9% · RS bench -6.6% · 1Y -2.4%3 of 10 weeks ahead 70% evidence |
| Exact sum: 10.9 + 9.2 + 10 + 9.1 = 39.2 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 22Unitech LtdUNITECH | 36.3/100Mixed-negative evidence69% evidence | ASLEEP | 18.0/35 Revenue 45.3% · PAT -10% · OPM change 15 pp 71% evidence | 3.5/25 ROCE 0.1% · OPM 6% 95% evidence | 10.0/20 P/E — · PEG — 0% evidence | 4.8/20 RS sector -28.9% · RS bench -29.3% · 1Y -42.7%3 of 12 weeks ahead 100% evidence |
| Exact sum: 18 + 3.5 + 10 + 4.8 = 36.3 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 23Kaveri Seed Company LtdKSCL | 36.0/100Mixed-negative evidence94% evidence | ASLEEP | 11.3/35 Revenue 1.4% · PAT -21.7% · OPM change 1 pp 100% evidence | 14.4/25 ROCE 18.8% · OPM 40% 100% evidence | 4.9/20 P/E 16.1× · PEG 3.12 100% evidence | 5.4/20 RS sector -17.2% · RS bench -18.3% · 1Y -27.6%3 of 11 weeks ahead 70% evidence |
| Exact sum: 11.3 + 14.4 + 4.9 + 5.4 = 36 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 24Delta Corp LtdDELTACORP | 35.5/100Mixed-negative evidence81% evidence | ASLEEP | 9.7/35 Revenue -9.3% · PAT -80% · OPM change -3 pp 95% evidence | 8.6/25 ROCE 5% · OPM 18% 95% evidence | 11.9/20 P/E 10.5× · PEG — 50% evidence | 5.3/20 RS sector -18.1% · RS bench -14.3% · 1Y -26.9%5 of 10 weeks ahead 70% evidence |
| Exact sum: 9.7 + 8.6 + 11.9 + 5.3 = 35.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 25Prozone Realty LtdPROZONER | 34.7/100Adverse evidence80% evidence | ASLEEP | 17.0/35 Revenue -9.9% · PAT 100% · OPM change 8.2 pp 95% evidence | 6.4/25 ROCE -1% · OPM -35.6% 95% evidence | 9.5/20 P/E 62.1× · PEG — 15% evidence | 1.8/20 RS sector -19.6% · RS bench -20% · 1Y -3.6%2 of 12 weeks ahead 100% evidence |
| Exact sum: 17 + 6.4 + 9.5 + 1.8 = 34.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 26Stanley Lifestyles LtdSTANLEY | 29.9/100Adverse evidence74% evidence | ASLEEP | 6.6/35 Revenue -5.6% · PAT -80% · OPM change -3.4 pp 95% evidence | 10.8/25 ROCE 6.4% · OPM 17.3% 95% evidence | 9.1/20 P/E 113× · PEG — 15% evidence | 3.4/20 RS sector -43.7% · RS bench -32% · 1Y -56.2%3 of 10 weeks ahead 70% evidence |
| Exact sum: 6.6 + 10.8 + 9.1 + 3.4 = 29.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 27Embassy Developments LtdEMBDL | 28.1/100Adverse evidence64% evidence | ASLEEP | 5.9/35 Revenue -46.6% · PAT -80% · OPM change -58.4 pp 71% evidence | 3.4/25 ROCE -2.4% · OPM -60% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 8.8/20 RS sector -12% · RS bench -12.7% · 1Y -35.7%7 of 12 weeks ahead 100% evidence |
| Exact sum: 5.9 + 3.4 + 10 + 8.8 = 28.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 28RattanIndia Enterprises LtdRTNINDIA | 17.6/100Adverse evidence74% evidence | ASLEEP | 2.7/35 Revenue 2.1% · PAT -80% · OPM change -23.9 pp 100% evidence | 1.0/25 ROCE -4.8% · OPM 2.1% 100% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.9/20 RS sector -32.1% · RS bench -25.1% · 1Y -41.7%5 of 10 weeks ahead 70% evidence |
| Exact sum: 2.7 + 1 + 10 + 3.9 = 17.6 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 29Central Mine Planning & Design Institute LtdCMPDI | 62.4/100Thin evidence · provisional38% evidence | ASLEEP | 22.1/35 Revenue — · PAT — · OPM change 8 pp 32% evidence | 20.1/25 ROCE 38.1% · OPM 30% 95% evidence | 10.2/20 P/E 25.9× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —4 of 5 weeks ahead 0% evidence |
| Exact sum: 22.1 + 20.1 + 10.2 + 10 = 62.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 30FlySBS Aviation LtdFLYSBS | 54.8/100Thin evidence · provisional41% evidence | TURNING | 15.4/35 Revenue — · PAT — · OPM change -8 pp 26% evidence | 19.4/25 ROCE 32.5% · OPM 21% 95% evidence | 11.2/20 P/E 12.6× · PEG — 15% evidence | 8.8/20 RS sector — · RS bench -12.2% · 1Y -1.6%3 of 10 weeks ahead 25% evidence |
| Exact sum: 15.4 + 19.4 + 11.2 + 8.8 = 54.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 31Qualitek Labs Ltd544091 | 53.5/100Thin evidence · provisional29% evidence | TURNING | 17.3/35 Revenue — · PAT — · OPM change -3 pp 7% evidence | 14.8/25 ROCE 11.9% · OPM 26% 76% evidence | 9.9/20 P/E 34× · PEG — 15% evidence | 11.5/20 RS sector — · RS bench 8.5% · 1Y —2 of 2 weeks ahead 25% evidence |
| Exact sum: 17.3 + 14.8 + 9.9 + 11.5 = 53.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 32Shree Vasu Logistics LtdSVLL | 52.0/100Thin evidence · provisional50% evidence | BREAKING OUT | 18.3/35 Revenue — · PAT — · OPM change 0.8 pp 26% evidence | 15.8/25 ROCE 12.9% · OPM 25.8% 95% evidence | 8.9/20 P/E 121× · PEG — 15% evidence | 9.0/20 RS sector -16.1% · RS bench 9.8% · 1Y -4.4%10 of 10 weeks ahead 70% evidence |
| Exact sum: 18.3 + 15.8 + 8.9 + 9 = 52 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 33Maagh Advertising & Marketing Services Ltd543624 | 49.8/100Thin evidence · provisional35% evidence | 18.4/35 Revenue — · PAT — · OPM change 275.6 pp 32% evidence | 9.1/25 ROCE -0.4% · OPM 55.6% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 12.3/20 RS sector — · RS bench 37% · 1Y —7 of 9 weeks ahead to 2025-03-19 25% evidence | |
| Exact sum: 18.4 + 9.1 + 10 + 12.3 = 49.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 34Indiqube Spaces LtdINDIQUBE | 47.3/100Thin evidence · provisional49% evidence | TURNING | 18.9/35 Revenue 38.9% · PAT 30.4% · OPM change 0 pp 71% evidence | 9.3/25 ROCE 6.4% · OPM 61% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 9.1/20 RS sector — · RS bench -6.3% · 1Y -16.7%2 of 10 weeks ahead 25% evidence |
| Exact sum: 18.9 + 9.3 + 10 + 9.1 = 47.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 35Tandhan Industries Ltd512062 | 46.6/100Thin evidence · provisional33% evidence | BREAKING OUT | 20.2/35 Revenue — · PAT 100% · OPM change — 33% evidence | 6.7/25 ROCE -0.3% · OPM 15.8% 76% evidence | 9.7/20 P/E 60.6× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y —6 of 6 weeks ahead 0% evidence |
| Exact sum: 20.2 + 6.7 + 9.7 + 10 = 46.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 36Shree Rama Newsprint LtdRAMANEWS | 45.0/100Thin evidence · provisional46% evidence | 14.1/35 Revenue -20% · PAT 69.8% · OPM change -8 pp 40% evidence | 6.1/25 ROCE 1.9% · OPM 8% 71% evidence | 10.0/20 P/E — · PEG — 0% evidence | 14.8/20 RS sector 9.7% · RS bench 10.5% · 1Y 9.2%11 of 12 weeks ahead to 2026-04-19 70% evidence | |
| Exact sum: 14.1 + 6.1 + 10 + 14.8 = 45 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Take Solutions Ltd's share price today?
Take Solutions Ltd trades at ₹43.6, +444.5% over the past year. The company is valued at ₹644 Cr. The stock sits at 87% of its 52-week range of ₹7–₹49, +35.1% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 29 weeks in. — as of 14 August 2026.
What were Take Solutions Ltd's latest quarterly results?
Take Solutions Ltd reported revenue of ₹0.0 Cr and net profit of ₹1.1 Cr for the Dec 25 quarter. Earnings per share were ₹0.08. — as of 14 August 2026.
What is Take Solutions Ltd's revenue?
Take Solutions Ltd reported revenue of ₹0.0 Cr in the Dec 25 quarter. For the full FY25 fiscal year, revenue was ₹0.0 Cr (−100.0%). — as of 14 August 2026.
What is Take Solutions Ltd's profit?
Take Solutions Ltd earned ₹1.1 Cr of net profit in the Dec 25 quarter, −97.7% year on year. Full-year FY25 profit was ₹37.5 Cr. — as of 14 August 2026.
What is Take Solutions Ltd's market cap?
Take Solutions Ltd's market capitalisation is ₹644 Cr at a share price of ₹43.6. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 14 August 2026.
What is Take Solutions Ltd's P/E ratio?
Take Solutions Ltd trades at a P/E of 3,222.0×, at the most expensive it has been in 10 years, against a long-run median of 13.4×. This is a comparison with the stock's own history, not a value call — as of 14 August 2026.
Does Take Solutions Ltd pay a dividend?
Not in its latest year — Take Solutions Ltd's dividend payout was 0% of profit in FY25. It did record a payout in 6 of its last 12 reported fiscal years, so there is a history but no current dividend. This page holds the payout ratio, not a per-share amount. — as of 14 August 2026.
Is Take Solutions Ltd overvalued?
On its own history, Take Solutions Ltd looks expensive: its P/E of 3,222.0× sits at the most expensive it has been in 10 years (long-run median 13.4×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 14 August 2026.
How is Take Solutions Ltd performing?
Take Solutions Ltd is in a confirmed uptrend, 29 weeks in. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 45 weeks. This describes what the data did, not a rating. — as of 14 August 2026.
Is Take Solutions Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 29 of stage 2), trading +35.1% versus its 200-day average and at 87% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 14 August 2026.
Is Take Solutions Ltd beating the market?
On recent form, yes — Take Solutions Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 45 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.2 years the stock moved −67% against the NIFTY 500's +277% — behind the index over the full window. — as of 14 August 2026.
Will Take Solutions Ltd's share price go up?
This page publishes no price forecast for Take Solutions Ltd. What it measures instead: the share price is ₹43.6, the price is in a confirmed uptrend 29 weeks in. Its P/E of 3,222.0× sits at the 100th percentile of its own 10-year range. — as of 14 August 2026.
Who owns Take Solutions Ltd?
Promoters hold 0.0% of Take Solutions Ltd, foreign institutions 0.3%, domestic institutions 0.0% and the public 99.7% (latest quarter). The biggest move on the register over the last two years: Promoters cut 53.4 points over 8 quarters. — as of 14 August 2026.
Does Take Solutions Ltd have too much debt?
No — Take Solutions Ltd's debt-to-equity is 0.00, and operating profit covers the interest bill −4×. FY25 borrowings were ₹0.0 Cr against equity of ₹20.5 Cr. The returns on this page are earned, not borrowed — as of 14 August 2026.
What is Take Solutions Ltd's capex?
Take Solutions Ltd spent ₹−87.0 Cr on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was ₹−30.0 Cr, with ₹0.0 Cr in capital work-in-progress — capacity paid for but not yet earning. — as of 14 August 2026.
What is Take Solutions Ltd's cash flow?
Take Solutions Ltd consumed ₹16.4 Cr of operating cash in FY25 — cash flowed out rather than in (free cash flow: ₹14.0 Cr). Operating cash was negative while the company reported a profit of ₹37.5 Cr. Cash-flow resolution for India is annual. — as of 14 August 2026.
Is Take Solutions Ltd's profit real cash?
Not fully — over the last 3 fiscal years, 55% of Take Solutions Ltd's reported profit arrived as operating cash. In FY25, operating cash was ₹−16.4 Cr against reported profit of ₹37.5 Cr. The cash then goes into a mix of the working-capital cycle and capacity. Cash-flow resolution is annual — as of 14 August 2026.
Where is Take Solutions Ltd in its business cycle?
Take Solutions Ltd's FY25 operating margin was −227.8%, against a 12-year band of −568.9%–20.7%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 14 August 2026.
What could break the Take Solutions Ltd story?
Biggest watch item: the P/E sits at the 100th percentile of its own range — the multiple has already done part of the work. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 14 August 2026.
Is Take Solutions Ltd a stock worth studying right now?
This is not investment advice. The machine read: Take Solutions Ltd's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 14 August 2026.